DocDollars

Astellas Us Technologies

IL · United States · Reporting entity ID 100000005408

Total reported 2019–2025
$25.7M
#271 of 2,960 reporting companies — 0% of all reported industry payments
$0 in general payments across 0 records, plus $25.7M in research funding across 1,863 records.

How it breaks down

Research funding $25,742,804

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Astellas Us Technologies reported $25.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #271 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 0 general payment records and 1,863 research records were filed.

Common questions about Astellas Us Technologies

How much has Astellas Us Technologies paid US doctors?

Astellas Us Technologies reported $25,742,804 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $0 in general payments, $25,742,804 in research funding.

How does Astellas Us Technologies rank among drug and device companies?

It ranks #271 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Astellas Us Technologies mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.